Predicting the outcome of therapy for pulmonary tuberculosis

Robert S. Wallis, Mark D. Perkins, Manijeh Phillips, Moses Joloba, Alice Namale, John L. Johnson, Christopher C. Whalen, Lucileia Teixeira, Barbara Demchuk, Reynaldo Dietze, Roy D. Mugerwa, Kathleen Eisenach, Jerrold J. Ellner

Research output: Contribution to journalArticle

Abstract

Patients vary considerably in their response to treatment of pulmonary tuberculosis. Although several studies have indicated that adverse outcomes are more likely in those patients with delayed sputum sterilization, few tools are available to identify those patients prospectively. In this study, multivariate models were developed to predict the response to therapy in a prospectively recruited cohort of 42 HIV-uninfected subjects with drug- sensitive tuberculosis. The cohort included 2 subjects whose initial response was followed by drug-sensitive relapse. The total duration of culture positivity was best predicted by a model that included sputum M. tuberculosis antigen 85 concentration on Day 14 of therapy, days-to-positive in BACTEC on Day 30, and the baseline radiographic extent of disease (R = 0.63). A model in which quantitative AFB microscopy replaced BACTEC also performed adequately (R = 0.58). Both models predicted delayed clearance of bacilli in both relapses (> 85th percentile of all subjects) using information collected during the first month of therapy. Stratification of patients according to anticipated response to therapy may allow TB treatment to be individualized, potentially offering superior outcomes and greater efficiency in resource utilization, and aiding in the conduct of clinical trials.

Original languageEnglish (US)
Pages (from-to)1076-1080
Number of pages5
JournalAmerican Journal of Respiratory and Critical Care Medicine
Volume161
Issue number4 I
StatePublished - 2000
Externally publishedYes

Fingerprint

Pulmonary Tuberculosis
Sputum
Tuberculosis
Therapeutics
Recurrence
Pharmaceutical Preparations
Bacillus
Microscopy
Clinical Trials
HIV
Antigens

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Wallis, R. S., Perkins, M. D., Phillips, M., Joloba, M., Namale, A., Johnson, J. L., ... Ellner, J. J. (2000). Predicting the outcome of therapy for pulmonary tuberculosis. American Journal of Respiratory and Critical Care Medicine, 161(4 I), 1076-1080.

Predicting the outcome of therapy for pulmonary tuberculosis. / Wallis, Robert S.; Perkins, Mark D.; Phillips, Manijeh; Joloba, Moses; Namale, Alice; Johnson, John L.; Whalen, Christopher C.; Teixeira, Lucileia; Demchuk, Barbara; Dietze, Reynaldo; Mugerwa, Roy D.; Eisenach, Kathleen; Ellner, Jerrold J.

In: American Journal of Respiratory and Critical Care Medicine, Vol. 161, No. 4 I, 2000, p. 1076-1080.

Research output: Contribution to journalArticle

Wallis, RS, Perkins, MD, Phillips, M, Joloba, M, Namale, A, Johnson, JL, Whalen, CC, Teixeira, L, Demchuk, B, Dietze, R, Mugerwa, RD, Eisenach, K & Ellner, JJ 2000, 'Predicting the outcome of therapy for pulmonary tuberculosis', American Journal of Respiratory and Critical Care Medicine, vol. 161, no. 4 I, pp. 1076-1080.
Wallis RS, Perkins MD, Phillips M, Joloba M, Namale A, Johnson JL et al. Predicting the outcome of therapy for pulmonary tuberculosis. American Journal of Respiratory and Critical Care Medicine. 2000;161(4 I):1076-1080.
Wallis, Robert S. ; Perkins, Mark D. ; Phillips, Manijeh ; Joloba, Moses ; Namale, Alice ; Johnson, John L. ; Whalen, Christopher C. ; Teixeira, Lucileia ; Demchuk, Barbara ; Dietze, Reynaldo ; Mugerwa, Roy D. ; Eisenach, Kathleen ; Ellner, Jerrold J. / Predicting the outcome of therapy for pulmonary tuberculosis. In: American Journal of Respiratory and Critical Care Medicine. 2000 ; Vol. 161, No. 4 I. pp. 1076-1080.
@article{275f5bce1bc94d93971044faa9e6afc6,
title = "Predicting the outcome of therapy for pulmonary tuberculosis",
abstract = "Patients vary considerably in their response to treatment of pulmonary tuberculosis. Although several studies have indicated that adverse outcomes are more likely in those patients with delayed sputum sterilization, few tools are available to identify those patients prospectively. In this study, multivariate models were developed to predict the response to therapy in a prospectively recruited cohort of 42 HIV-uninfected subjects with drug- sensitive tuberculosis. The cohort included 2 subjects whose initial response was followed by drug-sensitive relapse. The total duration of culture positivity was best predicted by a model that included sputum M. tuberculosis antigen 85 concentration on Day 14 of therapy, days-to-positive in BACTEC on Day 30, and the baseline radiographic extent of disease (R = 0.63). A model in which quantitative AFB microscopy replaced BACTEC also performed adequately (R = 0.58). Both models predicted delayed clearance of bacilli in both relapses (> 85th percentile of all subjects) using information collected during the first month of therapy. Stratification of patients according to anticipated response to therapy may allow TB treatment to be individualized, potentially offering superior outcomes and greater efficiency in resource utilization, and aiding in the conduct of clinical trials.",
author = "Wallis, {Robert S.} and Perkins, {Mark D.} and Manijeh Phillips and Moses Joloba and Alice Namale and Johnson, {John L.} and Whalen, {Christopher C.} and Lucileia Teixeira and Barbara Demchuk and Reynaldo Dietze and Mugerwa, {Roy D.} and Kathleen Eisenach and Ellner, {Jerrold J.}",
year = "2000",
language = "English (US)",
volume = "161",
pages = "1076--1080",
journal = "American Journal of Respiratory and Critical Care Medicine",
issn = "1073-449X",
publisher = "American Thoracic Society",
number = "4 I",

}

TY - JOUR

T1 - Predicting the outcome of therapy for pulmonary tuberculosis

AU - Wallis, Robert S.

AU - Perkins, Mark D.

AU - Phillips, Manijeh

AU - Joloba, Moses

AU - Namale, Alice

AU - Johnson, John L.

AU - Whalen, Christopher C.

AU - Teixeira, Lucileia

AU - Demchuk, Barbara

AU - Dietze, Reynaldo

AU - Mugerwa, Roy D.

AU - Eisenach, Kathleen

AU - Ellner, Jerrold J.

PY - 2000

Y1 - 2000

N2 - Patients vary considerably in their response to treatment of pulmonary tuberculosis. Although several studies have indicated that adverse outcomes are more likely in those patients with delayed sputum sterilization, few tools are available to identify those patients prospectively. In this study, multivariate models were developed to predict the response to therapy in a prospectively recruited cohort of 42 HIV-uninfected subjects with drug- sensitive tuberculosis. The cohort included 2 subjects whose initial response was followed by drug-sensitive relapse. The total duration of culture positivity was best predicted by a model that included sputum M. tuberculosis antigen 85 concentration on Day 14 of therapy, days-to-positive in BACTEC on Day 30, and the baseline radiographic extent of disease (R = 0.63). A model in which quantitative AFB microscopy replaced BACTEC also performed adequately (R = 0.58). Both models predicted delayed clearance of bacilli in both relapses (> 85th percentile of all subjects) using information collected during the first month of therapy. Stratification of patients according to anticipated response to therapy may allow TB treatment to be individualized, potentially offering superior outcomes and greater efficiency in resource utilization, and aiding in the conduct of clinical trials.

AB - Patients vary considerably in their response to treatment of pulmonary tuberculosis. Although several studies have indicated that adverse outcomes are more likely in those patients with delayed sputum sterilization, few tools are available to identify those patients prospectively. In this study, multivariate models were developed to predict the response to therapy in a prospectively recruited cohort of 42 HIV-uninfected subjects with drug- sensitive tuberculosis. The cohort included 2 subjects whose initial response was followed by drug-sensitive relapse. The total duration of culture positivity was best predicted by a model that included sputum M. tuberculosis antigen 85 concentration on Day 14 of therapy, days-to-positive in BACTEC on Day 30, and the baseline radiographic extent of disease (R = 0.63). A model in which quantitative AFB microscopy replaced BACTEC also performed adequately (R = 0.58). Both models predicted delayed clearance of bacilli in both relapses (> 85th percentile of all subjects) using information collected during the first month of therapy. Stratification of patients according to anticipated response to therapy may allow TB treatment to be individualized, potentially offering superior outcomes and greater efficiency in resource utilization, and aiding in the conduct of clinical trials.

UR - http://www.scopus.com/inward/record.url?scp=0034014653&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034014653&partnerID=8YFLogxK

M3 - Article

C2 - 10764293

AN - SCOPUS:0034014653

VL - 161

SP - 1076

EP - 1080

JO - American Journal of Respiratory and Critical Care Medicine

JF - American Journal of Respiratory and Critical Care Medicine

SN - 1073-449X

IS - 4 I

ER -